Nowadays, patients can tap into a multitude of information sources that empower them to influence decisions regarding their treatment. At the same time, payers are pushing for lower costs and restrict options available for HCPs. Can pharma companies still rely on the judgment of physicians alone when evaluating the market potential of a new product?
We’re invited to present at the annual EphMRA 2021 conference online on June 15-17 to discuss the importance of looking at multiple perspectives when forecasting the market potential of a new product. Our healthcare expert Elise Kocks and advanced analytics pro Nicolas Camargo will demonstrate how a decision influence framework helps to reconcile individual preferences and interaction styles into a single, reliable forecast, using and combining machine learning with other traditional analytical approaches.
Date and Time: Thursday June 17, 14:20 – 14:50 CEST